News

Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the S&P 500 gainers in early afternoon trading on May 20, surging by ...
TrialWire is the AI and algorithm-powered patient-recruitment and enrollment platform, purpose-built on Salesforce Health Cloud to guarantee best-in-class data and IP security.
Betsy Groves, Ph.D., is a Solutions Architect at Cohere, where she serves as a trusted technical advisor helping enterprise ...
U.S. health officials are investigating a new outbreak of salmonella illnesses tied to a Florida grower whose tainted ...
The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...
Three-dimensional printing is transforming medical care, letting the health care field shift from mass-produced solutions to customized treatments tailored to each patient’s needs. For instance, ...
Tempus AI is expanding its partnership with Verastem Oncology to develop a companion diagnostic (CDx) for the latter’s KRAS-mutant recurrent LGSOC combination treatment.
On May 8, 2025, the Food and Drug Administration (FDA) announced the completion of its generative artificial intelligence (AI) pilot program ...
Tempus' FDA-approved xT CDx test is being used as an investigational assay in Verastem's global Phase 3 RAMP-301 clinical trial.
AstraZeneca PLC (NASDAQ:AZN), a pharmaceutical and biotech firm based in Cambridge, UK, reported positive results from its ...
With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...
Traditionally, HER2 status has been determined by immunohistochemistry (IHC) and in situ hybridization (ISH), distinguishing ...